Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Mircera and Roxadustat in Renal Anemia during Maintenance Hemodialysis
ChiCTR2600124516Phase 4Completed
- Sponsor
- Guangdong Second Provincial General Hospital
- Start
- May 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Epoetin alfa RB and roxadustat in anaemia (2 arms), sponsored by Guangdong Second Provincial General Hospital. Primary endpoint: hemoglobin. Started May 2026; status: completed.
02
Drugs
Epoetin alfa RBroxadustat
03
Conditions
anaemia
Beyond the preview
Go deeper on ChiCTR2600124516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124516.